| BCBS Highmark Penn Medicare Advantage | Inotuzumab Ozogamicin (Besponsa) | 2024-04-29 |
| BCBS Highmark NY and West NY | Implantable Pulmonary Artery Pressure Measurement Device | 2024-04-29 |
| BCBS Highmark NY and West NY | New York Oncology Mandate | 2024-04-29 |
| BCBS Highmark Delaware | Implantable Pulmonary Artery Pressure Measurement Device | 2024-04-29 |
| BCBS Highmark Delaware | Inotuzumab Ozogamicin (Besponsa) | 2024-04-29 |
| BCBS Highmark Delaware | Spesolimab (Spevigo) | 2024-04-29 |
| BCBS Highmark West Virginia | Inotuzumab Ozogamicin (Besponsa) | 2024-04-29 |
| BCBS Highmark West Virginia | Spesolimab (Spevigo) | 2024-04-29 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Implantable Pulmonary Artery Pressure Measurement Device | 2024-04-29 |
| BCBS Highmark NY and West NY | Spesolimab (Spevigo) | 2024-04-29 |